The 5-HT1A antagonist WAY 100635 can block the low-dose locomotor stimulant effects of cocaine

被引：20
|
作者：
Carey, R
Damianopoulos, E
DePalma, G
机构：
[1] VA Med Ctr, Res & Dev 151, Syracuse, NY 13210 USA
[2] SUNY Hlth Sci Ctr, Syracuse, NY 13210 USA
来源：
BRAIN RESEARCH | 2000年 / 862卷 / 1-2期
关键词：
cocaine; locomotion; 5-HT1A receptors; WAY; 100635; dopamine;
D O I：
10.1016/S0006-8993(00)02084-9
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Cocaine treatments of 2.5, 5.0, 10.0 and 15.0 mg/kg induced dose-dependent increases in locomotor behavior. This cocaine-induced increase in locomotion was blocked if the animals were administered the selective 5-HT1A antagonist, WAY 100635 (0.4 mg/kg) prior to the cocaine treatment. The 0.4-mg/kg dose of WAY 100635 did not affect locomotor behavior or alter cocaine availability in brain. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码：242 / 246
页数：5
相关论文
共 50 条
  • [41] COCAINE PRODUCES LOW-DOSE LOCOMOTOR DEPRESSANT EFFECTS IN MICE
    GEORGE, FR
    PSYCHOPHARMACOLOGY, 1989, 99 (02) : 147 - 150
  • [42] PLASMA-GLUCOSE AND CARDIOVASCULAR STUDIES IN THE RAT WITH WAY100635, A SELECTIVE, POTENT 5-HT1A RECEPTOR ANTAGONIST
    CRITCHLEY, DJP
    WILSON, KMR
    MIDDLEFELL, VC
    DOURISH, CT
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U57 - U57
  • [43] Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses
    Trillat, AC
    Malagié, I
    Mathé-Allainmat, M
    Anmela, MC
    Jacquot, C
    Langlois, M
    Gardier, AM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 347 (01) : 41 - 49
  • [44] WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by blockade of hippocampal NMDA receptors
    Carli, M
    Silva, S
    Balducci, C
    Samanin, R
    NEUROPHARMACOLOGY, 1999, 38 (08) : 1165 - 1173
  • [45] Catalepsy induced by the 5-HT1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram
    Eltayb, A
    Svensson, TH
    Ahlenius, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 411 (03) : 275 - 277
  • [46] Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects
    Carey, RJ
    DePalma, G
    Damianopoulos, E
    Shanahan, A
    Müller, CP
    Huston, JP
    BRAIN RESEARCH, 2005, 1034 (1-2) : 162 - 171
  • [47] EFFECT OF THE PUTATIVE 5-HT1A ANTAGONIST WAY100635 ON 5-HT NEURONAL FIRING IN THE GUINEA-PIG DORSAL RAPHE NUCLEUS
    MUNDEY, MK
    FLETCHER, A
    MARSDEN, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U49 - U49
  • [48] QUANTITATIVE AUTORADIOGRAPHIC CHARACTERIZATION OF THE BINDING OF [H-3] WAY-100635, A SELECTIVE 5-HT1A RECEPTOR ANTAGONIST
    KHAWAJA, X
    BRAIN RESEARCH, 1995, 673 (02) : 217 - 225
  • [49] Investigation of the effect of WAY-100635 (5-HT1A receptor antagonist) on 5-HT-induced contraction in different regions of the suncus murinus intestine
    Javid, FA
    Naylor, RJ
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135
  • [50] Effects of a 5-HT1A receptor agonist (8-OH-DPAT) and antagonist (WAY-100635) on free-operant timing behaviour
    Body, S
    Kheramin, S
    Mobini, S
    Ho, MY
    Velazquez-Martínez, DN
    Bradshaw, CM
    Szabadi, E
    JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : A25 - A25
12345